Anthera Pharmaceuticals Overview

  • Founded
  • 2004
Founded
  • Status
  • Public
  • Employees
  • 21
Employees
  • Stock Symbol
  • ANTH
Stock Symbol
  • Share Price
  • $0.03
  • (As of Thursday Closing)

Anthera Pharmaceuticals General Information

Description

Anthera Pharmaceuticals Inc is a biopharmaceutical company that focuses on developing and commercializing products to treat serious diseases associated with inflammation, including cardiovascular and autoimmune diseases. The company currently has one Phase 3-ready clinical program and two Phase 2 clinical programs. It was established in 2004.

Contact Information

Website
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Stock Exchange
PINX
Primary Office
  • 25801 Industrial Boulevard
  • Suite B
  • Hayward, CA 94545
  • United States
+1 (510) 000-0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Anthera Pharmaceuticals Stock Performance

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.03 $0.03 $0.02 - $0.07 64.3K

Anthera Pharmaceuticals Financials Summary

In Thousands,
USD
TTM 31-Mar-2018 FY 2017 31-Dec-2017 FY 2016 31-Dec-2016 FY 2015 31-Dec-2015
EV 5,610 17,109 (1,648) 129,260
Revenue 0 0 145 3,185
EBITDA (22,994) (26,593) (55,257) (34,935)
Net Income (23,391) (26,874) (55,523) (35,220)
Total Assets 8,811 3,673 23,471 48,125
Total Debt 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Anthera Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Anthera Pharmaceuticals‘s full profile, request access.

Request a free trial

Anthera Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Anthera Pharmaceuticals Inc is a biopharmaceutical company that focuses on developing and commercializing products to tr
Biotechnology
Hayward, CA
21 As of 2017
00000
00000000 00000

00000 00

tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitati
000000000000000
Durham, NC
000 As of 0000
00000
000000 - 000 00000

00000000

la pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt moll
0000000000000
Charlottesville, VA
00 As of 0000
000.00
00000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Anthera Pharmaceuticals Competitors (37)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Aerie Pharmaceuticals Formerly VC-backed Durham, NC 000 00000 000000 - 000 00000
000000000 00000000 Formerly VC-backed Charlottesville, VA 00 000.00 00000000 000.00
0000000 Formerly VC-backed Summit, NJ 0000 000.00 000000&0 000.00
000000 Formerly VC-backed San Diego, CA 00 000.00 000000&0 000.00
0000000 0000000000 Corporate Backed or Acquired South San Francisco, CA 000 00000 000000&0 00000
You’re viewing 5 of 37 competitors. Get the full list »

Anthera Pharmaceuticals Executive Team (12)

Name Title Board Seat Contact Info
Charles Olson Co-Chief Technology Officer
May Liu Chief Accounting Officer, Accounting & Senior Vice President
You’re viewing 2 of 12 executive team members. Get the full list »

Anthera Pharmaceuticals Board Members (14)

Name Representing Role Since
00000 00000 Self Board Member 000 0000
00000 0000000 Self Board Member 000 0000
00000000000 000000 00.0 Self Board Member 000 0000
00000 00000000 Self Board Member 000 0000
0000 00000 Anthera Pharmaceuticals Chairman & Board Member 000 0000
You’re viewing 5 of 14 board members. Get the full list »

Anthera Pharmaceuticals Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Anthera Pharmaceuticals Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Anthera Pharmaceuticals‘s full profile, request access.

Request a free trial